Total Payments
$2,067
2024 Payments
$957.15
Companies
18
Transactions
103
Medicare Patients
4,232
Medicare Billing
$240,786
Payment Breakdown by Category
Food & Beverage$1,777 (86.0%)
Education$289.98 (14.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,777 | 100 | 86.0% |
| Education | $289.98 | 3 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $616.14 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $286.63 | 13 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $266.87 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $152.55 | 5 | $0 (2024) |
| Lilly USA, LLC | $112.71 | 6 | $0 (2024) |
| Novo Nordisk Inc | $111.91 | 6 | $0 (2024) |
| GENZYME CORPORATION | $84.02 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $81.94 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $81.30 | 5 | $0 (2024) |
| UCB, Inc. | $65.85 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $957.15 | 40 | ABBVIE INC. ($222.90) |
| 2023 | $541.56 | 30 | ABBVIE INC. ($230.63) |
| 2022 | $335.01 | 17 | Sun Pharmaceutical Industries Inc. ($152.31) |
| 2021 | $232.80 | 16 | Janssen Biotech, Inc. ($52.50) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $105.12 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $81.60 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $90.00 | General |
| 04/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Biological | ||||||
| 04/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Respiratory | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,360 | 1,946 | $334,809 | $84,520 |
| 2022 | 20 | 1,704 | 2,714 | $381,080 | $88,459 |
| 2021 | 15 | 1,168 | 1,927 | $261,153 | $67,807 |
Total Patients
4,232
Total Services
6,587
Medicare Billing
$240,786
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 349 | $90,740 | $28,191 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 146 | 146 | $53,436 | $15,666 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 212 | 285 | $48,630 | $12,244 | 25.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 28 | $16,464 | $4,954 | 30.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 64 | 64 | $11,712 | $4,852 | 41.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 187 | 202 | $19,418 | $3,696 | 19.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 129 | 137 | $25,779 | $3,308 | 12.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 14 | $5,852 | $1,761 | 30.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 31 | $8,711 | $1,602 | 18.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $6,540 | $1,540 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $3,526 | $1,296 | 36.8% |
| 11401 | Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 13 | $4,434 | $1,047 | 23.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $5,047 | $918.11 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $9,166 | $896.91 | 9.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 97 | 339 | $16,725 | $810.44 | 4.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 51 | 64 | $618.00 | $521.98 | 84.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 19 | 101 | $1,717 | $424.20 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,445 | $383.84 | 15.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 34 | $2,676 | $264.92 | 9.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,173 | $143.55 | 12.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 396 | 462 | $74,382 | $22,093 | 29.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 282 | 390 | $37,050 | $11,917 | 32.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 255 | 334 | $59,118 | $11,388 | 19.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 163 | 163 | $39,120 | $9,134 | 23.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 87 | 92 | $32,568 | $7,019 | 21.6% |
About Shannon Johnston, NP-C
Shannon Johnston, NP-C is a Nurse Practitioner healthcare provider based in Low Moor, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1427544089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shannon Johnston, NP-C has received a total of $2,067 in payments from pharmaceutical and medical device companies, with $957.15 received in 2024. These payments were reported across 103 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,777).
As a Medicare-enrolled provider, Johnston has provided services to 4,232 Medicare beneficiaries, totaling 6,587 services with total Medicare billing of $240,786. Data is available for 3 years (2021–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Low Moor, VA
- Active Since 07/06/2018
- Last Updated 06/05/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1427544089
Products in Payments
- BREZTRI (Drug) $184.85
- QULIPTA (Drug) $151.83
- SKYRIZI (Biological) $139.75
- UBRELVY (Drug) $123.65
- VRAYLAR (Drug) $115.97
- DUPIXENT (Biological) $115.51
- REXULTI (Drug) $102.12
- Rybelsus (Drug) $74.23
- ILUMYA (Biological) $66.89
- Cimzia (Drug) $65.85
- REMICADE (Biological) $64.99
- MOUNJARO (Drug) $64.54
- Veozah (Drug) $62.55
- FARXIGA (Drug) $60.17
- Cologuard Collection Kit (Device) $53.20
- YUPELRI (Drug) $47.86
- AIRSUPRA (Drug) $41.61
- RINVOQ (Biological) $31.25
- JARDIANCE (Drug) $30.02
- EUCRISA (Drug) $22.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.